Page 367 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPTEr 23 Mast Cells, Basophils, and Mastocytosis 347

mast cells from the cloned cells in the gastric mucosa of W/Wv mice. Am 39. Lee DM, Friend DS, Gurish MF, et al. Mast cells: a cellular link between
J Pathol 1987;129:168–76. autoantibodies and inflammatory arthritis. Science 2002;297:1689–92.
16. Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat 40. Secor VH, Secor WE, Gutekunst CA, et al. Mast cells are essential for
Rev Immunol 2014;14:478–94. early onset and severe disease in a murine model of multiple sclerosis. J
17. Balzar S, Fajt ML, Comhair SA, et al. Mast cell phenotype, location, and Exp Med 2000;191:813–22.
activation in severe asthma. Data from the Severe Asthma Research 41. Younan G, Suber F, Xing W, et al. The inflammatory response after an
Program. Am J Respir Crit Care Med 2011;183:299–309. epidermal burn depends on the activities of mouse mast cell proteases 4
18. Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of and 5. J Immunol 2010;185:7681–90.
airway smooth muscle in asthma. N Engl J Med 2002;346:1699–705. 42. Tsai M, Starkl P, Marichal T, et al. Testing the “toxin hypothesis of
19. Bradding P, Arthur G. Mast cells in asthma—state of the art. Clin Exp allergy”: mast cells, IgE, and innate and acquired immune responses to
Allergy 2016;46:194–263. venoms. Curr Opin Immunol 2015;36:80–7.
20. Kitamura Y, Shimada M, Go S, et al. Distribution of mast-cell precursors 43. Groschwitz KR, Ahrens R, Osterfeld H, et al. Mast cells regulate
in hematopoietic and lymphopoietic tissues of mice. J Exp Med homeostatic intestinal epithelial migration and barrier function by a
1979;150:482–90. chymase/Mcpt4-dependent mechanism. Proc Natl Acad Sci USA
21. Irani AM, Craig SS, DeBlois G, et al. Deficiency of the tryptase-positive, 2009;106:22381–6.
chymase-negative mast cell type in gastrointestinal mucosa of patients 44. Garfield RE, Irani AM, Schwartz LB, et al. Structural and functional
with defective T lymphocyte function. J Immunol 1987;138:4381–6. comparison of mast cells in the pregnant versus nonpregnant human
22. Denburg JA, Telizyn S, Messner H, et al. Heterogeneity of human uterus. Am J Obstet Gynecol 2006;194:261–7.
peripheral blood eosinophil-type colonies: evidence for a common 45. Lange M, Niedoszytko M, Renke J, et al. Clinical aspects of paediatric
basophil-eosinophil progenitor. Blood 1985;66:312–18. mastocytosis: a review of 101 cases. J Eur Acad Dermatol Venereol
23. Saito H, Hatake K, Dvorak AM, et al. Selective differentiation and 2013;27:97–102.
proliferation of hematopoietic cells induced by recombinant human 46. Cohen SS, Skovbo S, Vestergaard H, et al. Epidemiology of systemic
interleukins. Proc Natl Acad Sci USA 1988;85:2288–92. mastocytosis in Denmark. Br J Haematol 2014;166:521–8.
24. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, et al. Eosinophil granule 47. Bibi S, Langenfeld F, Jeanningros S, et al. Molecular defects in
proteins in peripheral blood granulocytes. J Leukoc Biol 1992;52:611–18. mastocytosis: KIT and beyond KIT. Immunol Allergy Clin North Am
25. Schneider LA, Schlenner SM, Feyerabend TB, et al. Molecular mechanism 2014;34(2):239–62.
of mast cell mediated innate defense against endothelin and snake venom 48. Sokol H, Georgin-Lavialle S, Canioni D, et al. Gastrointestinal
sarafotoxin. J Exp Med 2007;204:2629–39. manifestations in mastocytosis: a study of 83 patients. J Allergy Clin
26. Douaiher J, Succar J, Lancerotto L, et al. Development of mast cells and Immunol 2013;132:866–73.e1-3.
importance of their tryptase and chymase serine proteases in 49. Moura DS, Georgin-Lavialle S, Gaillard R, et al. Neuropsychological
inflammation and wound healing. Adv Immunol 2014;122:211–52. features of adult mastocytosis. Immunol Allergy Clin North Am
27. Kanaoka Y, Maekawa A, Austen KF. Identification of GPR99 protein as a 2014;34:407–22.
potential third cysteinyl leukotriene receptor with a preference for 50. van der Veer E, van der Goot W, de Monchy JG, et al. High prevalence of
leukotriene E4 ligand. J Biol Chem 2013;288:10967–72. fractures and osteoporosis in patients with indolent systemic
28. Chen CY, Lee JB, Liu B, et al. Induction of interleukin-9-producing mastocytosis. Allergy 2012;67:431–8.
mucosal mast cells promotes susceptibility to IgE-mediated experimental 51. Bonadonna P, Lombardo C, Zanotti R. Mastocytosis and allergic diseases.
food allergy. Immunity 2015;43:788–802. J Investig Allergol Clin Immunol 2014;24:288–97.
29. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med 52. Pardanani A. Systemic mastocytosis in adults: 2015 update on diagnosis,
2012;18:693–704. risk stratification, and management. Am J Hematol 2015;90:250–62.
30. Rivera J, Fierro NA, Olivera A, et al. New insights on mast cell activation 53. Horny HP, Metcalfe DD, Bennett JM, et al. Mastocytosis. In: Swerdlow
via the high affinity receptor for IgE. Adv Immunol 2008;98:85–120. SH, Campo E, Harris NL, editors. WHO classification of tumors of
31. Galli SJ, Metcalfe DD, Arver DA, et al. Basophils and mast cells and their hematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. p.
disorders. In: Kaushansky KLM, Beutler E, Kipps TJ, et al, editors. 54–63.
Williams hematology. 8th ed. New York: McGraw-Hill Medical; 2010. p. 54. Valent P, Akin C, Arock M, et al. Definitions, criteria and global
915–32. classification of mast cell disorders with special reference to mast cell
32. McNeil BD, Pundir P, Meeker S, et al. Identification of a mast-cell-specific activation syndromes: a consensus proposal. Int Arch Allergy Immunol
receptor crucial for pseudo-allergic drug reactions. Nature 2012;157:215–25.
2015;519:237–41. 55. Gotlib J, Kluin-Nelemans HC, George TI, et al. Efficacy and safety of
33. Kajiwara N, Sasaki T, Bradding P, et al. Activation of human mast cells midostaurin in advanced systemic mastocytosis. N Engl J Med
through the platelet-activating factor receptor. J Allergy Clin Immunol 2016;374:2530–41.
2010;125:1137–45. 56. Valent P, Sperr WR, Schwartz LB, et al. Diagnosis and classification of
34. Modena BD, Dazy K, White AA. Emerging concepts: mast cell mast cell proliferative disorders: delineation from immunologic diseases
involvement in allergic diseases. Transl Res 2016;174:98–121. and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol
35. Siddiqui S, Mistry V, Doe C, et al. Airway hyperresponsiveness is 2004;114:3.
dissociated from airway wall structural remodeling. J Allergy Clin 57. Lim KH, Tefferi A, Lasho TL, et al. Systemic mastocytosis in 342
Immunol 2008;122:335–41, 341.e1-3. consecutive adults: survival studies and prognostic factors. Blood
36. Laidlaw TM, Boyce JA. Aspirin-exacerbated respiratory disease—new 2009;113:5727–36.
prime suspects. N Engl J Med 2016;374:484–8. 58. Matsuoka K, Shitara H, Taya C, et al. Novel basophil- or
37. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. eosinophil-depleted mouse models for functional analyses of allergic
Nat Rev Immunol 2010;10:440–52. inflammation. PLoS ONE 2013;8:e60958.
38. Sun J, Sukhova GK, Wolters PJ, et al. Mast cells promote atherosclerosis 59. Soter NA. Mastocytosis and the skin. Hematol Oncol Clin North Am
by releasing proinflammatory cytokines. Nat Med 2007;13:719–24. 2000;14(3):537–55, vi.